Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion type Assertion NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_head.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion wasGeneratedBy ECO_0000203 NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_provenance.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion wasDerivedFrom befree-20150227 NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_provenance.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion SIO_000772 10597191 NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_provenance.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion evidence source_evidence_literature NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_provenance.
- NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_assertion description "[As HLA-B35 is one of the most frequent HLA-B specificities, being present in about 20% of Caucasian individuals, it may be a useful target for peptide-based immunotherapy of melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451782.RA2NThFI_wruiK0e2W_ormVdGOtoggcrmuiEi3D-oYChQ130_provenance.